Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system

Irx3 作为心室传导系统成熟和规范的关键转录调节因子

基本信息

  • 批准号:
    RGPIN-2018-06870
  • 负责人:
  • 金额:
    $ 2.7万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

The ventricular conduction system (VCS) is a network of biological electric wires comprised of a specialized form of cardiac muscle cells (cardiomyocytes), which enables the rapid electric propagation to trigger a synchronous ventricular contraction. We have demonstrated that a member of Iroquois (Irx) transcription factor family, Irx3 is specifically expressed in the VCS, while loss of Irx3 led to slow electrical conduction, suggesting an essential role in the VCS function. This phenotype in Irx3KO mouse heart can be attributed to abnormal expression of gap junction Cx40 (Gja5) and Cx43 (Gja1) genes as well as VCS structural hypoplasia caused by a postnatal maturation defect. Nevertheless, molecular mechanisms underlying Irx3-mediated VCS specification and maturation (i.e. downstream target genes) remain largely unknown. Interestingly, our preliminary study using neonatal mouse ventricular myocytes revealed that Irx3 overexpression increased the spontaneous beating rate with induction of molecular signatures of the VCS, such as hyperpolarization-activated cyclic nucleotide-gated channel genes (Hcn2 and Hcn4) as well as Purkinje fiber marker Contactin2 (Cntn2). These data suggest Irx3 overexpression can transform contractile myocytes into VCS-like cells. Moreover, we found that Irx3 exerts synergistic effects on the activation of VCS-specific genes with Tbx3, while Tbx3 function in this process is dependent on Irx3. These novel observations suggest that transcriptional programing capacity of Irx3 in cooperation with Tbx3 will provide a promising tool to dissect and understand their molecular mechanisms in the VCS specification. Here we propose to further delineate the molecular mechanisms of Irx3 in the VCS as follows: (1) To gain molecular insights into the specification and differentiation of VCS cells, and to establish a mechanistic basis of Irx3-medated VCS programming, we will construct a gene regulatory network of Irx3 in the heart with a particular emphasis on interactions with Tbx3; (2) we will validate Irx3 and Tbx3 target genes and characterize electrophysiological properties of Irx3-Tbx3 programmed VCS-like cells; and (3) We will investigate the in vivo effect of Irx3-mediated VCS programming and specification by utilizing mice overexpressing or lacking Irx3 in the heart. Particularly, we will test whether VCS specification capacity of Irx3 is dependent on the developmental stages by inducing Irx3 overexpression in different time points (e.g. embryo, neonatal and adult). The studies outlined in this proposal will unveil novel mechanistic detail related to the regulatory action of Irx3 in the establishment and specification of the VCS. It will also be fundamental to build my research program which is aimed to investigate the genetic regulation of heart development and function.
心室传导系统(VCS)是由一种特殊形式的心肌细胞(心肌细胞)组成的生物电线网络,它使快速的电传播能够触发同步的心室收缩。我们已经证明,IRX3是易洛魁(Iroquis,IRX)转录因子家族的成员之一,在VCS中特异表达,而IRX3的缺失导致电传导缓慢,提示IRX3在VCS功能中起着至关重要的作用。IRX3KO小鼠心脏的这种表型可归因于缝隙连接Cx40(Gja5)和Cx43(Gja1)基因的异常表达以及出生后成熟缺陷导致的VCS结构发育不良。然而,IRX3介导的VCS规范和成熟的分子机制(即下游靶基因)在很大程度上仍不清楚。有趣的是,我们用新生小鼠心肌细胞进行的初步研究表明,IRX3的过表达通过诱导VCS的分子特征而增加自发搏动频率,例如超极化激活的环核苷酸门控通道基因(HCn2和HCN4)以及浦肯野纤维标记Contactin 2(Cntn2)。这些数据表明,IRX3过表达可以将收缩心肌细胞转化为VCS样细胞。此外,我们还发现IRX3对Tbx3激活VCS特异性基因具有协同作用,而Tbx3在这一过程中的作用依赖于IRX3。这些新颖的观察结果表明,IRX3和TBX3的转录编程能力将为剖析和理解VCS规范中的分子机制提供一个有前途的工具。在这里,我们建议进一步描述IRX3在VCS中的分子机制如下:(1)为了获得对VCS细胞规范和分化的分子见解,并建立IRX3介导的VCS编程的机制基础,我们将在心脏构建IRX3基因调控网络,重点关注与TBX3的相互作用;(2)我们将验证IRX3和TBX3靶基因并鉴定IRX3-TBX3编程的VCS样细胞的电生理特性;以及(3)我们将利用心脏过表达或缺失IRX3的小鼠研究IRX3介导的VCS编程和规范的体内效应。特别是,我们将通过在不同的时间点(例如胚胎、新生儿和成人)诱导IRX3的过度表达来测试IRX3的VCS规范能力是否依赖于发育阶段。这项提案中概述的研究将揭示与IRX3在VCS的建立和规范中的调节作用相关的新的机制细节。这也将是建立我的研究项目的基础,该项目旨在调查心脏发育和功能的遗传调节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kim, KyoungHan其他文献

Kim, KyoungHan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kim, KyoungHan', 18)}}的其他基金

Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system
Irx3 作为心室传导系统成熟和规范的关键转录调节因子
  • 批准号:
    RGPIN-2018-06870
  • 财政年份:
    2021
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Discovery Grants Program - Individual
Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system
Irx3 作为心室传导系统成熟和规范的关键转录调节因子
  • 批准号:
    RGPIN-2018-06870
  • 财政年份:
    2020
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Discovery Grants Program - Individual
Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system
Irx3 作为心室传导系统成熟和规范的关键转录调节因子
  • 批准号:
    RGPIN-2018-06870
  • 财政年份:
    2019
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Discovery Grants Program - Individual
Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system
Irx3 作为心室传导系统成熟和规范的关键转录调节因子
  • 批准号:
    DGECR-2018-00008
  • 财政年份:
    2018
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Discovery Launch Supplement
Irx3 as a critical transcriptional regulator in the maturation and specification of the ventricular conduction system
Irx3 作为心室传导系统成熟和规范的关键转录调节因子
  • 批准号:
    RGPIN-2018-06870
  • 财政年份:
    2018
  • 资助金额:
    $ 2.7万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

堆垒基与Narkiewicz常数的研究
  • 批准号:
    11226279
  • 批准年份:
    2012
  • 资助金额:
    3.0 万元
  • 项目类别:
    数学天元基金项目

相似海外基金

Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
肺肌成纤维细胞去分化和纤维化消退取决于 cAMP 介导的 HuR 抑制。
  • 批准号:
    10661944
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Define the molecular bases for cryptococcal adaptation to host conditions by the RAM pathway
通过 RAM 途径定义隐球菌适应宿主条件的分子基础
  • 批准号:
    10627371
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Comprehensive Analyses of HOXB13-regulated Transcriptional programs critical for Prostate Cancer Progression
HOXB13 调控的转录程序的综合分析对前列腺癌进展至关重要
  • 批准号:
    10904447
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Transcriptional regulation of neural progenitor divisions and cell fate in the developing cortex
发育中皮层神经祖细胞分裂和细胞命运的转录调控
  • 批准号:
    10659677
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Immune-Metabolic Regulation of Biliary Atresia
胆道闭锁的免疫代谢调节
  • 批准号:
    10645435
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Utilizing Causal X-Linked Intellectual Disability Variants to Gain Insight into the O-GlcNAc Transferase Enzyme
利用因果 X 连锁智力障碍变异来深入了解 O-GlcNAc 转移酶
  • 批准号:
    10607359
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Identifying mechanisms ofsynapse maturation at neuronal subtype resolution
识别神经元亚型分辨率下突触成熟的机制
  • 批准号:
    10739241
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunction
Nrf2 和运动在减轻肺动脉高压引起的血管功能障碍中的作用
  • 批准号:
    10750500
  • 财政年份:
    2023
  • 资助金额:
    $ 2.7万
  • 项目类别:
Molecular regulation of cell fate and progenitor function in the distal human respiratory airways
人类远端呼吸道细胞命运和祖细胞功能的分子调控
  • 批准号:
    10427894
  • 财政年份:
    2022
  • 资助金额:
    $ 2.7万
  • 项目类别:
Investigating the Role of MBNL1 in Maintaining Cardiomyocyte Terminal Differentiation.
研究 MBNL1 在维持心肌细胞终末分化中的作用。
  • 批准号:
    10462155
  • 财政年份:
    2022
  • 资助金额:
    $ 2.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了